Jenburkt Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

141.97

136.75

123.98

109.29

118.89

Operating profit

33.12

30.37

27.26

19.84

19.74

Interest

0.27

0.37

0.43

0.47

0.53

Gross profit

37.52

35.12

31.77

23.68

23.44

EPS (Rs)

58.86

55.76

48.58

35.96

32.40

Other income

4.67

5.12

4.95

4.31

4.22

Stock adjustment

-0.39

1.34

-2.28

3.18

-0.49

Raw material

8.39

11.12

11.74

6.78

9.65

Power and fuel

-

-

-

-

-

Employee expenses

42.49

38.81

36.49

32.38

36.51

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

58.36

55.12

50.78

47.11

53.47

Provisions made

-

-

-

-

-

Depreciation

2.34

2.26

1.90

2.04

2.30

Taxation

9.20

8.26

7.57

5.14

6.27

Net profit / loss

25.98

24.61

22.30

16.50

14.87

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

4.41

4.41

4.59

4.59

4.59

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

23.33

22.21

21.98

18.15

16.61

GPM (%)

25.58

24.76

24.64

20.84

19.04

NPM (%)

17.72

17.34

17.29

14.53

12.08